• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[木瓜凝乳蛋白酶化学溶核治疗患者的致敏反应]

[Sensitization to chymopapain in patients treated with chemonucleolysis].

作者信息

García-Ortega P, Ramírez Ferreiras W, Sancho A, Urías S, Cisteró A

机构信息

Unidad de Alergia, Servico de Medicina Interna, Hospital Joan XXIII, Tarragona.

出版信息

Med Clin (Barc). 1991 Mar 23;96(11):410-2.

PMID:2046428
Abstract

BACKGROUND

Chemonucleolysis (intradisk administration of chymopapain) is a procedure to treat intervertebral disk hernia. Recently, its use has been questioned due to the development of anaphylactic reactions in patients sensitized to chymopapain. The prevalence of sensitization to chymopapain has been evaluated before and after chemonucleolysis, and the possibility to establish risk groups through the allergy history has been assessed.

METHODS

104 consecutive patients who were candidates to chemonucleolysis were evaluated with an allergy questionnaire, cutaneous tests to aeroallergens and to chymopapain, and chymopapain-specific IgE. The two latter tests were repeated one month after chemonucleolysis.

RESULTS

Only 2 patients (1.9%) showed evidence of chymopapain sensitization before the procedure. Sixteen patients (16%) were sensitized after chemonucleolysis. None of the possible risk factors evaluated in the allergy questionnaire (atopy, drug allergy, papaya occupational exposure or use of additives, cosmetics or drugs containing papaine) were significantly related with the risk of sensitization to chymopapain.

CONCLUSIONS

The prevalence of chymopapain sensitization in the study group was low. The allergy questionnaire (atopy, drug allergy, use of papaya, occupational history did not identify sensitized patients. Cutaneous tests and specific IgE are the best method to detect chymopapain sensitization. The remarkable rate of sensitization after chemonucleolysis may partially limit the usefulness of the procedure.

摘要

背景

化学髓核溶解术(椎间盘内注射木瓜凝乳蛋白酶)是一种治疗椎间盘突出症的方法。近来,由于对木瓜凝乳蛋白酶敏感的患者会发生过敏反应,该方法的应用受到质疑。在化学髓核溶解术前和术后评估了对木瓜凝乳蛋白酶敏感的发生率,并评估了通过过敏史确定危险人群的可能性。

方法

对104例连续的化学髓核溶解术候选患者进行了过敏问卷调查、针对气传变应原和木瓜凝乳蛋白酶的皮肤试验以及木瓜凝乳蛋白酶特异性IgE检测。后两项检测在化学髓核溶解术后1个月重复进行。

结果

仅2例患者(1.9%)在术前显示有木瓜凝乳蛋白酶敏感的证据。16例患者(16%)在化学髓核溶解术后出现敏感。过敏问卷调查中评估的所有可能危险因素(特应性、药物过敏、木瓜职业暴露或使用含木瓜蛋白酶的添加剂、化妆品或药物)均与木瓜凝乳蛋白酶敏感风险无显著相关性。

结论

研究组中木瓜凝乳蛋白酶敏感的发生率较低。过敏问卷调查(特应性、药物过敏、木瓜使用情况、职业史)未识别出敏感患者。皮肤试验和特异性IgE是检测木瓜凝乳蛋白酶敏感的最佳方法。化学髓核溶解术后显著的敏感率可能会部分限制该方法的实用性。

相似文献

1
[Sensitization to chymopapain in patients treated with chemonucleolysis].[木瓜凝乳蛋白酶化学溶核治疗患者的致敏反应]
Med Clin (Barc). 1991 Mar 23;96(11):410-2.
2
Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing.通过皮肤糜蛋白酶测试筛选化学核溶解术候选者来预防糜蛋白酶过敏反应。
Clin Orthop Relat Res. 1988 Sep(234):12-5.
3
[Chymopapain allergy. Diagnostic value of a skin test before and after chemonucleolysis].[木瓜凝乳蛋白酶过敏。化学溶核术前及术后皮肤试验的诊断价值]
Neurochirurgia (Stuttg). 1985 Mar;28(2):51-6. doi: 10.1055/s-2008-1054183.
4
[Incidence and prevention of allergic reactions following chemonucleolysis with chymopapain].
Neurochirurgia (Stuttg). 1986 Sep;29 Suppl 1:149-53. doi: 10.1055/s-2008-1054100.
5
Chymopapain allergy: case reports and identification of patients at risk for chymopapain anaphylaxis.木瓜凝乳蛋白酶过敏:病例报告及木瓜凝乳蛋白酶过敏反应高危患者的识别
Clin Orthop Relat Res. 1984 Sep(188):139-43.
6
Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing. A preliminary report.
Clin Orthop Relat Res. 1987 Aug(221):202-6.
7
[Detection of patients at risk of allergy to chymopapain before and after chemonucleolysis. Choice of preventive medication].
Acta Orthop Belg. 1987;53(2):213-20.
8
A 17% prevalence of anaphylaxis during chemonucleolysis among 35 patients who underwent a repeat chemonucleolysis procedure.
Spine (Phila Pa 1976). 1988 Jan;13(1):135.
9
Incidence and risk factors for latent sensitization to chymopapain: predictive skin-prick tests in 700 candidates for chemonucleolysis.
Clin Exp Allergy. 1994 May;24(5):471-6. doi: 10.1111/j.1365-2222.1994.tb00936.x.
10
[Skin tests and chymopapain-specific immunoglobulins E after chemonucleolysis].
Presse Med. 1987 May 16;16(18):881-4.

引用本文的文献

1
Safety evaluation of the food enzyme endo-polygalacturonase from the non-genetically modified strain MUCL 55013.来自非转基因菌株MUCL 55013的食品酶内切多聚半乳糖醛酸酶的安全性评估。
EFSA J. 2023 Nov 20;21(11):e08397. doi: 10.2903/j.efsa.2023.8397. eCollection 2023 Nov.
2
Safety evaluation of a food enzyme containing endo-polygalacturonase and pectin lyase activities from the non-genetically modified strain NZYM-PE.来自非转基因菌株NZYM-PE的一种具有内切多聚半乳糖醛酸酶和果胶裂解酶活性的食品酶的安全性评估。
EFSA J. 2023 Jul 26;21(7):e08151. doi: 10.2903/j.efsa.2023.8151. eCollection 2023 Jul.
3
Safety evaluation of the food enzyme endo-polygalacturonase from the genetically modified strain EPG.
来自转基因菌株EPG的食品酶内切多聚半乳糖醛酸酶的安全性评估。
EFSA J. 2023 Mar 8;21(3):e07837. doi: 10.2903/j.efsa.2023.7837. eCollection 2023 Mar.
4
Safety evaluation of the food enzyme containing endo-polygalacturonase and endo-1,3(4)-β-glucanase from the non-genetically modified strain NZYM-RE.来自非转基因菌株NZYM-RE的含有内切多聚半乳糖醛酸酶和内切-1,3(4)-β-葡聚糖酶的食品酶的安全性评估。
EFSA J. 2022 Dec 21;20(12):e07648. doi: 10.2903/j.efsa.2022.7648. eCollection 2022 Dec.